← All companies

VALN

Valneva SE

VALN Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$5.07

+0.10 +2.01%

Key statistics

from XBRL data in SEC filings

Market cap

$880M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$4.75 – $12.25

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 22, 2026 6-K Jun 25, 2026 6-K Jun 5, 2026 6-K Jun 1, 2026 6-K May 13, 2026 6-K May 5, 2026 6-K Apr 30, 2026 6-K Mar 26, 2026 6-K Mar 23, 2026 6-K Mar 18, 2026 20-F Mar 17, 2026 6-K Mar 9, 2026 6-K Mar 2, 2026 6-K Feb 19, 2026 6-K Feb 13, 2026 6-K Feb 3, 2026 6-K Jan 20, 2026 6-K Jan 9, 2026 6-K Dec 31, 2025 6-K Dec 11, 2025 6-K Nov 28, 2025 6-K Nov 26, 2025 6-K Nov 20, 2025 6-K Nov 4, 2025 6-K/A Oct 6, 2025 6-K Oct 6, 2025 6-K Oct 6, 2025 6-K Sep 3, 2025 6-K Aug 25, 2025 6-K Aug 18, 2025 6-K Aug 12, 2025 6-K Aug 7, 2025 6-K Jul 11, 2025 6-K Jun 26, 2025 6-K Jun 25, 2025 6-K Jun 5, 2025 6-K Jun 4, 2025 6-K May 27, 2025 6-K May 12, 2025 6-K May 7, 2025